Difference between revisions of "Amphetamines"

From Powerbase
Jump to: navigation, search
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Amphetamine''' is a psychostimulant drug that is known to produce increased wakefulness and focus in association with decreased fatigue and appetite. Drug tolerance is developed rapidly in amphetamine abuse, thereby the amount of the drug that is needed to satisfy the addiction needs to be increased at regular intervals.<ref>Amphetamines, [http://www.merck.com/mmhe/sec25/ch312/ch312c.html Drug Use and Abuse: Merck Manual Home Edition], Accessed 21-January-2010</ref>.
+
'''Amphetamine''' is a psychostimulant drug that is known to produce increased wakefulness and focus in association with decreased fatigue and appetite. Drug tolerance is developed rapidly in amphetamine abuse, and therefore the amount of the drug that is needed to satisfy the addiction needs to be increased at regular intervals.<ref>Amphetamines, [http://www.merck.com/mmhe/sec25/ch312/ch312c.html Drug Use and Abuse: Merck Manual Home Edition], Accessed 21-January-2010</ref>.
  
 
Amphetamine is a potent drug that acts by increasing levels of dopamine and norepinephrine in the brain, inducing euphoria.<ref>Drevets, W et al, (2001), [http://www-psych.stanford.edu/~knutson/rab/drevets01.pdf Amphetamine-Induced Dopamine Release in Human Ventral Striatum Correlates with Euphoria], ''Psychiatry'', volume 49, pages 81–96, Accessed 21-January-2010</ref>. Amphetemines include prescription drugs commonly used to treat attention-deficit hyperactivity disorder (ADHD).  
 
Amphetamine is a potent drug that acts by increasing levels of dopamine and norepinephrine in the brain, inducing euphoria.<ref>Drevets, W et al, (2001), [http://www-psych.stanford.edu/~knutson/rab/drevets01.pdf Amphetamine-Induced Dopamine Release in Human Ventral Striatum Correlates with Euphoria], ''Psychiatry'', volume 49, pages 81–96, Accessed 21-January-2010</ref>. Amphetemines include prescription drugs commonly used to treat attention-deficit hyperactivity disorder (ADHD).  
  
 
==Legal issues==
 
==Legal issues==
In the United Kingdom, amphetamines are regarded as Class B drugs under the 1971 Misuse of Drugs Act. The maximum penalty for unauthorized possession is five years in prison and an unlimited fine. The maximum penalty for illegal supply is fourteen years in prison and an unlimited fine<ref>Class A, B and C drugs, [http://www.homeoffice.gov.uk/drugs/drugs-law/Class-a-b-c/ Class A, B and C Drugs], The Home Office, Accessed 21-January-2010</ref>
+
In the United Kingdom, amphetamines are regarded as Class B drugs under the 1971 Misuse of Drugs Act. The maximum penalty for unauthorized possession is five years in prison and an unlimited fine. The maximum penalty for illegal supply is fourteen years in prison and an unlimited fine.<ref>Class A, B and C drugs, [http://www.homeoffice.gov.uk/drugs/drugs-law/Class-a-b-c/ Class A, B and C Drugs], The Home Office, Accessed 21-January-2010</ref>
  
 
==Resources==
 
==Resources==

Latest revision as of 22:47, 21 January 2010

Amphetamine is a psychostimulant drug that is known to produce increased wakefulness and focus in association with decreased fatigue and appetite. Drug tolerance is developed rapidly in amphetamine abuse, and therefore the amount of the drug that is needed to satisfy the addiction needs to be increased at regular intervals.[1].

Amphetamine is a potent drug that acts by increasing levels of dopamine and norepinephrine in the brain, inducing euphoria.[2]. Amphetemines include prescription drugs commonly used to treat attention-deficit hyperactivity disorder (ADHD).

Legal issues

In the United Kingdom, amphetamines are regarded as Class B drugs under the 1971 Misuse of Drugs Act. The maximum penalty for unauthorized possession is five years in prison and an unlimited fine. The maximum penalty for illegal supply is fourteen years in prison and an unlimited fine.[3]

Resources


Notes

  1. Amphetamines, Drug Use and Abuse: Merck Manual Home Edition, Accessed 21-January-2010
  2. Drevets, W et al, (2001), Amphetamine-Induced Dopamine Release in Human Ventral Striatum Correlates with Euphoria, Psychiatry, volume 49, pages 81–96, Accessed 21-January-2010
  3. Class A, B and C drugs, Class A, B and C Drugs, The Home Office, Accessed 21-January-2010